LiqTech International Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $15.4M+5.7% YoYTTM through 30 Jun 2026
Net Income -$9.8MTTM through 30 Jun 2026
Free Cash Flow -$8.8MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 7.6% |
| EBITDA Margin | -46.5% |
| Operating Margin | -50.6% |
| Net Margin | -63.2% |
Returns
-82.4%ROE
-34.5%ROA
Balance Sheet Health
Debt / Equity0.58x
Current Ratio2.50x
Net Debt$929.6K
Cash & Equivalents$2.7M
Quality Metrics
Altman Z-Score-2.29
Piotroski F-Score4 / 9
FCF Margin-57.1%
Rule of 40-17.1
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $16.5M
Diluted EPSFY2025: $-0.89
Dividend
No dividend
Capital Allocation
R&D Spend$1.2M
Capex Intensity3.7%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Systems and Aftermarket | $8.2M | +49.0% | View detailsCentral to long-term strategy with growing adoption of silicon carbide membrane technology across multiple end markets. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.